Alain Robillard

2.1k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Alain Robillard is a scholar working on Psychiatry and Mental health, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alain Robillard has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Ophthalmology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alain Robillard's work include Dementia and Cognitive Impairment Research (9 papers), Retinal Imaging and Analysis (5 papers) and Glaucoma and retinal disorders (5 papers). Alain Robillard is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Retinal Imaging and Analysis (5 papers) and Glaucoma and retinal disorders (5 papers). Alain Robillard collaborates with scholars based in Canada, United States and Belgium. Alain Robillard's co-authors include Sibel Tekin, Peter Quarg, Andrew Lees, Alberto Albanese, Dag Aarsland, Werner Poewe, Günther Deuschl, Franck Durif, Teus van Laar and Erik Ch. Wolters and has published in prestigious journals such as New England Journal of Medicine, SLEEP and Neurobiology of Aging.

In The Last Decade

Alain Robillard

18 papers receiving 1.3k citations

Hit Papers

Rivastigmine for Dementia Associated with Parkinson's Dis... 2004 2026 2011 2018 2004 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Robillard Canada 14 634 536 268 232 190 18 1.4k
Jón Snædal Iceland 25 185 0.3× 489 0.9× 468 1.7× 406 1.8× 77 0.4× 68 1.6k
Peter Dal‐Bianco Austria 26 124 0.2× 634 1.2× 309 1.2× 337 1.5× 121 0.6× 75 1.5k
Lea T. Drye United States 24 168 0.3× 940 1.8× 206 0.8× 399 1.7× 415 2.2× 46 1.9k
Anette Lolk Denmark 10 1.6k 2.5× 799 1.5× 402 1.5× 390 1.7× 90 0.5× 12 2.2k
Raymund Schwan France 22 103 0.2× 430 0.8× 332 1.2× 66 0.3× 213 1.1× 134 1.5k
B. Seltzer United States 18 105 0.2× 563 1.1× 699 2.6× 203 0.9× 232 1.2× 31 1.5k
Ingo Kilimann Germany 24 143 0.2× 681 1.3× 323 1.2× 362 1.6× 76 0.4× 58 1.4k
F. Bylsma United States 23 585 0.9× 992 1.9× 333 1.2× 534 2.3× 104 0.5× 37 2.1k
L Linzmayer Austria 21 104 0.2× 289 0.5× 371 1.4× 93 0.4× 219 1.2× 84 1.2k
Esther S.C. Korf Netherlands 15 147 0.2× 791 1.5× 318 1.2× 569 2.5× 44 0.2× 20 1.5k

Countries citing papers authored by Alain Robillard

Since Specialization
Citations

This map shows the geographic impact of Alain Robillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Robillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Robillard more than expected).

Fields of papers citing papers by Alain Robillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Robillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Robillard. The network helps show where Alain Robillard may publish in the future.

Co-authorship network of co-authors of Alain Robillard

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Robillard. A scholar is included among the top collaborators of Alain Robillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Robillard. Alain Robillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sylvestre, Jean‐Philippe, Jean‐Paul Soucy, Sylvain Beaulieu, et al.. (2019). Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 610–617. 41 indexed citations
2.
Soucy, Jean‐Paul, Jean‐Philippe Sylvestre, Jean Daniel Arbour, et al.. (2018). IC‐P‐190: AN AMYLOID LIGAND‐FREE OPTICAL RETINAL IMAGING METHOD TO PREDICT CEREBRAL AMYLOID PET STATUS. Alzheimer s & Dementia. 14(7S_Part_2). 2 indexed citations
3.
Gauthier, Serge, et al.. (2013). Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer’s disease: the EMBRACE study. Current Medical Research and Opinion. 29(8). 989–1000. 14 indexed citations
4.
Richards, Blake A., Howard Chertkow, Vivek Kumar Singh, et al.. (2008). Patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Neurobiology of Aging. 30(10). 1626–1636. 28 indexed citations
5.
Chow, Tiffany W., et al.. (2008). 100 Years After Alzheimer: Contemporary Neurology Practice Assessment of Referrals for Dementia. American Journal of Alzheimer s Disease & Other Dementias®. 23(6). 516–527. 5 indexed citations
6.
Robillard, Alain. (2007). Clinical diagnosis of dementia. Alzheimer s & Dementia. 3(4). 292–298. 41 indexed citations
7.
Gagnon, Jean‐François, Dominique Petit, Maria Livia Fantini, et al.. (2006). REM Sleep Behavior Disorder and REM Sleep Without Atonia in Probable Alzheimer Disease. SLEEP. 29(10). 1321–1325. 88 indexed citations
8.
Herrmann, Nathan, Krista L. Lanctôt, R Sambrook, et al.. (2006). The contribution of neuropsychiatric symptoms to the cost of dementia care. International Journal of Geriatric Psychiatry. 21(10). 972–976. 183 indexed citations
9.
Emre, Murat, Dag Aarsland, Alberto Albanese, et al.. (2004). Rivastigmine for Dementia Associated with Parkinson's Disease. New England Journal of Medicine. 351(24). 2509–2518. 793 indexed citations breakdown →
10.
Rockwood, Kenneth, Sandra E. Black, Alain Robillard, & Isabelle Lussier. (2004). Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey. International Journal of Geriatric Psychiatry. 19(10). 954–960. 27 indexed citations
11.
Sambrook, R, Nathan Herrmann, Réjean Hébert, et al.. (2004). Canadian Outcomes Study in Dementia: Study Methods and Patient Characteristics. The Canadian Journal of Psychiatry. 49(7). 417–427. 22 indexed citations
12.
Kergoat, Hélène, et al.. (2002). Visual Retinocortical Function in Dementia of the Alzheimer Type. Gerontology. 48(4). 197–203. 40 indexed citations
13.
Kergoat, Hélène, et al.. (2001). Normal Optic Nerve Head Topography in the Early Stages of Dementia of the Alzheimer Type. Dementia and Geriatric Cognitive Disorders. 12(6). 359–363. 16 indexed citations
15.
Kergoat, Hélène, et al.. (2001). An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. Acta Ophthalmologica Scandinavica. 79(2). 187–191. 50 indexed citations
16.
Kergoat, Marie‐Jeanne, et al.. (2001). Neuroretinal function is normal in early dementia of the Alzheimer type. Neurobiology of Aging. 22(4). 691–695. 29 indexed citations
17.
Baladi, Jean‐François, Peter Bailey, Sandra E. Black, et al.. (2000). Rivastigmine for alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications. Clinical Therapeutics. 22(12). 1549–1561. 11 indexed citations
18.
Robillard, Alain, et al.. (1994). Translation of Clinical and Neuropsychological Instruments into French: The CERAD Experience. Age and Ageing. 23(6). 449–451. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026